Macular edema Clinical Trials
Conditions / Macular edema
Delta Trials records 189 clinical trials for Macular edema in its publicly accessible dataset. From the full dataset, 8 actively seeking eligible participants and 126 trials have reached completion. This research is conducted across 687 study locations around the world. An additional 55 trials are active but not currently open for enrollment. Since 2020, 25 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
189
Total Trials
8
Recruiting
126
Completed
55
Other Active
25
Terminated since 2020
687
Study Locations
Browse by location (687 total)
- Paris, France 19 trialsAll trials in Paris, France
- Paris, France 19 trialsAll trials in Paris, France
- Budapest, Hungary 15 trialsAll trials in Budapest, Hungary
- London, United Kingdom 15 trialsAll trials in London, United Kingdom
- Barcelona, Spain 14 trialsAll trials in Barcelona, Spain
- Créteil, France 12 trialsAll trials in Créteil, France
- Créteil, France 12 trialsAll trials in Créteil, France
- Debrecen, Hungary 11 trialsAll trials in Debrecen, Hungary
- San Antonio, United States 11 trialsAll trials in San Antonio, United States
- Phoenix, United States 11 trialsAll trials in Phoenix, United States
- Houston, United States 11 trialsAll trials in Houston, United States
- Coimbra, Portugal 11 trialsAll trials in Coimbra, Portugal
- Philadelphia, United States 10 trialsAll trials in Philadelphia, United States
- Abilene, United States 10 trialsAll trials in Abilene, United States
- Prague, Czechia 10 trialsAll trials in Prague, Czechia
- Beijing, China 10 trialsAll trials in Beijing, China
- Baltimore, United States 10 trialsAll trials in Baltimore, United States
- Beverly Hills, United States 9 trialsAll trials in Beverly Hills, United States
- Shanghai, China 9 trialsAll trials in Shanghai, China
- Seoul, South Korea 9 trialsAll trials in Seoul, South Korea